CN115820567A - High-temperature-resistant helper phage TR-3 and application thereof - Google Patents
High-temperature-resistant helper phage TR-3 and application thereof Download PDFInfo
- Publication number
- CN115820567A CN115820567A CN202210887757.1A CN202210887757A CN115820567A CN 115820567 A CN115820567 A CN 115820567A CN 202210887757 A CN202210887757 A CN 202210887757A CN 115820567 A CN115820567 A CN 115820567A
- Authority
- CN
- China
- Prior art keywords
- phage
- helper phage
- helper
- m13ko7
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明提供了一种耐高温辅助噬菌体TR‑3及其应用,涉及生物技术领域。本发明提供的耐高温辅助噬菌体TR‑3是经过多轮的高温处理(98℃)、感染和扩增得到的辅助噬菌体M13KO7的突变体,TR‑3在98℃条件下稳定存活,感染效率高,并保留了以正常效率包装pIII融合展示噬菌粒的能力以及高质量ssDNA提取,因此,可用于噬菌体ssDNA制备、噬菌体展示库的构建和稳定蛋白质变体的分离。
The invention provides a high-temperature-resistant helper phage TR‑3 and its application, relating to the field of biotechnology. The high-temperature-resistant helper phage TR-3 provided by the present invention is a mutant of the helper phage M13KO7 obtained through multiple rounds of high-temperature treatment (98°C), infection and amplification. TR-3 survives stably at 98°C and has high infection efficiency , and retains the ability to package pIII fusion display phagemids with normal efficiency and high-quality ssDNA extraction, therefore, it can be used for phage ssDNA preparation, phage display library construction and isolation of stable protein variants.
Description
技术领域technical field
本发明涉及生物技术领域,尤其是涉及一种耐高温辅助噬菌体TR-3及其应用。The invention relates to the field of biotechnology, in particular to a high-temperature-resistant helper phage TR-3 and its application.
背景技术Background technique
通常用于噬菌体展示的载体有两类:即噬菌体载体和噬菌粒(phagemid)载体。由于噬菌粒载体具有基因组较小、易于操作、可插入的片段较大、转化效率高、产生的重组体更加稳定等优点,目前最常用的就是噬菌粒载体。噬菌粒只含有噬菌体的部分遗传信息,因而建库和晒库都需要辅助噬菌体(helper phage)为宿主细胞的噬菌粒DNA提供复制和包装所需的蛋白酶和外壳蛋白。There are two types of vectors commonly used for phage display: phage vectors and phagemid vectors. Because phagemid vectors have the advantages of small genome, easy operation, large insertable fragments, high transformation efficiency, and more stable recombinants, phagemid vectors are currently the most commonly used. Phagemids only contain part of the genetic information of phages, so both library construction and drying require helper phages to provide proteases and coat proteins required for replication and packaging of phagemid DNA in host cells.
辅助噬菌体是一类DNA复制效率极低的丝状噬菌体的突变型,其基因组DNA具有M13噬菌体的所有功能基因,但是IG区是缺陷的,因而其pII蛋白对这个序列不能有效识别,辅助噬菌体本身的DNA也就不能进行单链复制,于是能够为噬菌粒提供pII蛋白和包装蛋白。辅助噬菌体的IG区的失活,同时使得其本身的基因不能表达。当含有重组基因的噬菌粒转染至大肠杆菌后,再用辅助噬菌体进行超感染,辅助噬菌体合成的pII蛋白就会优先识别噬菌粒上的正常基因间隔区,启动滚环复制,产生ssDNA,这样所产生的子代噬菌体外壳蛋白所包装的ssDNA主要是来自含有重组基因的噬菌粒的DNA,并同时展示噬菌粒编码的pIII或pVIII与外源肽段的融合蛋白和辅助噬菌体编码的野生型的pIII或pVIII蛋白,确保重组噬菌体能正常感染、组装和增殖。Helper phage is a mutant type of filamentous phage with extremely low DNA replication efficiency. Its genomic DNA has all the functional genes of M13 phage, but the IG region is defective, so its pII protein cannot effectively recognize this sequence. Helper phage itself The DNA can not be single-stranded replication, so it can provide pII protein and packaging protein for phagemid. The inactivation of the IG region of the helper phage also renders its own genes unable to express. When the phagemid containing the recombinant gene is transfected into E. coli and superinfected with helper phage, the pII protein synthesized by the helper phage will preferentially recognize the normal intergenic region on the phagemid, initiate rolling circle replication, and produce ssDNA , the ssDNA packaged by the progeny phage coat protein produced in this way is mainly from the DNA of the phagemid containing the recombinant gene, and at the same time display the fusion protein of pIII or pVIII encoded by the phagemid and the foreign peptide and the helper phage code The wild-type pIII or pVIII protein ensures that the recombinant phage can infect, assemble and proliferate normally.
通过不同的机制构建的辅助噬菌体主要有两大类,即含全长gIII的辅助噬菌体、gIII删除或gIII缺陷的辅助噬菌体。含全长gIII的辅助噬菌体主要包括M13KO7、R408和VCSM13。M13KO7是M13噬菌体的一个突变体,带有一个质粒复制起点、卡那霉素抗性基因以及G6125T的突变基因II。已有研究表明,子代噬菌体颗粒的高效生产和单链DNA产量与细胞生长温度密切相关,较高的温度会促使细胞快速增长、造成潜在的细胞裂解和部分噬菌体失活,甚至丢失噬菌体感染细胞的能力,最终只能获得低产量且稳定性差的噬菌体颗粒,影响噬菌体单链DNA的产量和噬菌体展示抗体库的滴度。例如,与37℃培养相比,在25℃条件下培养CJ236细胞,可显著改善ssDNA的产量和纯度,这可能与辅助噬菌体M13K07本身对温度具有较低的耐受性相关,可见,辅助噬菌体的适宜温度与细胞的适宜温度存在差异。所以,提高辅助噬菌体的耐受性,对噬菌体展示具有重要意义。There are two main categories of helper phages constructed by different mechanisms, namely, helper phages containing full-length gIII, and helper phages with gIII deletion or gIII deficiency. Helper phages containing full-length gIII mainly include M13KO7, R408 and VCSM13. M13KO7 is a mutant of M13 phage with a plasmid origin of replication, kanamycin resistance gene, and mutant gene II of G6125T. Previous studies have shown that the high-efficiency production of progeny phage particles and the yield of single-stranded DNA are closely related to cell growth temperature. Higher temperatures will promote rapid cell growth, resulting in potential cell lysis and inactivation of some phages, and even loss of phage-infected cells. In the end, only low-yield and poorly stable phage particles can be obtained, which affects the yield of phage single-stranded DNA and the titer of the phage-displayed antibody library. For example, cultivating CJ236 cells at 25°C can significantly improve the yield and purity of ssDNA compared with 37°C, which may be related to the lower temperature tolerance of helper phage M13K07 itself. It can be seen that the helper phage There is a difference between the optimum temperature and the optimum temperature of the cells. Therefore, improving the tolerance of helper phage is of great significance for phage display.
有鉴于此,特提出本发明。In view of this, the present invention is proposed.
发明内容Contents of the invention
本发明的目的之一在于提供一种耐高温辅助噬菌体TR-3,以至少解决现有技术中存在的技术问题之一。One of the objectives of the present invention is to provide a high temperature resistant helper phage TR-3, so as to at least solve one of the technical problems in the prior art.
本发明的目的之二在于提供上述耐高温辅助噬菌体TR-3的制备方法。The second object of the present invention is to provide a method for preparing the above-mentioned thermostable helper phage TR-3.
本发明的目的之三在于提供上述耐高温辅助噬菌体TR-3的应用。The third object of the present invention is to provide the application of the above-mentioned thermostable helper phage TR-3.
本发明的目的之四在于提供一种噬菌体展示系统。The fourth object of the present invention is to provide a phage display system.
本发明的目的之五在于提供一种试剂盒。The fifth object of the present invention is to provide a kit.
本发明的目的之六在于提供上述噬菌体展示系统的应用。The sixth object of the present invention is to provide the application of the above phage display system.
为了实现本发明的上述目的,特采用以下技术方案:In order to realize the above-mentioned purpose of the present invention, special adopt following technical scheme:
一种耐高温辅助噬菌体TR-3,所述耐高温辅助噬菌体TR-3的氨基酸序列与辅助噬菌体M13KO7的氨基酸序列不同之处仅在于:A high-temperature-resistant helper phage TR-3, the amino acid sequence of the high-temperature-resistant helper phage TR-3 differs from the amino acid sequence of the helper phage M13KO7 only in that:
耐高温辅助噬菌体TR-3的pVIII发生了V6A突变;The pVIII of the thermostable helper phage TR-3 has a V6A mutation;
耐高温辅助噬菌体TR-3的pIII发生了G287R和S378G突变;以及G287R and S378G mutations occurred in pIII of thermostable helper phage TR-3; and
耐高温辅助噬菌体TR-3的pIV发生了I87N突变。I87N mutation occurred in the pIV of thermostable helper phage TR-3.
一种耐高温辅助噬菌体TR-3的制备方法,对辅助噬菌体M13KO7进行如下改造:A method for preparing a high-temperature-resistant helper phage TR-3, wherein the helper phage M13KO7 is modified as follows:
将辅助噬菌体M13KO7的pVIII进行V6A突变;The pVIII of helper phage M13KO7 was subjected to V6A mutation;
将辅助噬菌体M13KO7的pIII进行G287R和S378G突变;以及G287R and S378G mutations were performed on the pill of helper phage M13KO7; and
将辅助噬菌体M13KO7的pIV进行I87N突变。The pIV of helper phage M13KO7 was mutated with I87N.
上述耐高温辅助噬菌体TR-3在噬菌体展示中的应用。Application of the above-mentioned thermostable helper phage TR-3 in phage display.
上述耐高温辅助噬菌体TR-3在制备ssDNA中的应用。Application of the above-mentioned thermostable helper phage TR-3 in the preparation of ssDNA.
上述耐高温辅助噬菌体TR-3在制备抗体库中的应用。Application of the above-mentioned high-temperature resistant helper phage TR-3 in the preparation of an antibody library.
上述耐高温辅助噬菌体TR-3在构建噬菌体展示库中的应用。Application of the above-mentioned thermostable helper phage TR-3 in constructing a phage display library.
一种含有上述耐高温辅助噬菌体TR-3的噬菌体展示系统。A phage display system containing the above-mentioned thermostable helper phage TR-3.
进一步地,所述噬菌体展示系统还包括噬菌粒。Further, the phage display system also includes phagemids.
一种含有上述噬菌体展示系统的试剂盒。A kit containing the above phage display system.
上述噬菌体展示系统在制备ssDNA或抗体库中的应用。Application of the above-mentioned phage display system in the preparation of ssDNA or antibody library.
与现有技术相比,本发明的有益效果如下:Compared with the prior art, the beneficial effects of the present invention are as follows:
本发明提供的耐高温辅助噬菌体TR-3是经过多轮的高温处理(98℃)、感染和扩增得到的辅助噬菌体M13KO7的突变体,TR-3在98℃条件下稳定存活,感染效率高,并保留了以正常效率包装pIII融合展示噬菌粒的能力以及高质量ssDNA提取,因此,可用于噬菌体ssDNA制备、噬菌体展示库的构建和稳定蛋白质变体的分离。The high-temperature-resistant helper phage TR-3 provided by the present invention is a mutant of the helper phage M13KO7 obtained through multiple rounds of high-temperature treatment (98°C), infection and amplification. TR-3 survives stably at 98°C and has high infection efficiency , and retains the ability to package pIII fusion display phagemids with normal efficiency and high-quality ssDNA extraction, therefore, it can be used for phage ssDNA preparation, phage display library construction and isolation of stable protein variants.
附图说明Description of drawings
为了更清楚地说明本发明具体实施方式或现有技术中的技术方案,下面将对具体实施方式或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图是本发明的一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the specific implementation of the present invention or the technical solutions in the prior art, the following will briefly introduce the accompanying drawings that need to be used in the specific implementation or description of the prior art. Obviously, the accompanying drawings in the following description The drawings show some implementations of the present invention, and those skilled in the art can obtain other drawings based on these drawings without any creative work.
图1为本发明实施例3提供的耐高温辅助噬菌体TR-3提取ssDNA。Fig. 1 is the extraction of ssDNA by the thermostable helper phage TR-3 provided in Example 3 of the present invention.
具体实施方式Detailed ways
下面将结合实施例对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions of the present invention will be clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are part of the embodiments of the present invention, but not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
为了解决现有技术中由于辅助噬菌体的耐受性差从而导致的噬菌体展示技术产品产量低、纯度差的问题,发明人经高温胁迫,筛选得到本发明提供的耐高温辅助噬菌体TR-3,经检测发现,耐高温辅助噬菌体TR-3的氨基酸序列与辅助噬菌体M13KO7的氨基酸序列不同之处仅在于:耐高温辅助噬菌体TR-3的pVIII发生了V6A突变、pIII发生了G287R和S378G突变、以及、pIV发生了I87N突变。In order to solve the problem of low yield and poor purity of phage display technology products in the prior art due to the poor tolerance of helper phages, the inventor obtained the high-temperature-resistant helper phage TR-3 provided by the present invention through screening under high temperature stress. After testing It was found that the amino acid sequence of the thermostable helper phage TR-3 differs from that of the helper phage M13KO7 only in that pVIII of the thermostable helper phage TR-3 has the V6A mutation, pIII has the G287R and S378G mutations, and pIV An I87N mutation occurred.
耐高温辅助噬菌体TR-3的pVIII蛋白序列如SEQ ID NO.1所示,pIII蛋白序列如SEQ ID NO.2所示,pIV蛋白序列如SEQ ID NO.3所示。The pVIII protein sequence of the thermostable helper phage TR-3 is shown in SEQ ID NO.1, the pIII protein sequence is shown in SEQ ID NO.2, and the pIV protein sequence is shown in SEQ ID NO.3.
本发明提供的TR-3在98℃条件下稳定存活,感染效率高,并保留了以正常效率包装pIII融合展示噬菌粒的能力以及高质量ssDNA提取,可以克服目前辅助噬菌体耐受性差的缺陷。The TR-3 provided by the present invention survives stably at 98°C, has high infection efficiency, and retains the ability to package pIII fusion display phagemids with normal efficiency and high-quality ssDNA extraction, which can overcome the defect of poor tolerance of the current helper phages .
本发明的耐高温辅助噬菌体TR-3可以广泛应用于噬菌体展示技术中,具体可以应用于ssDNA的制备、抗体库的制备等。含有TR-3和噬菌粒的噬菌体展示系统可以适应较大范围的细胞培养温度,进行高效生产。The high-temperature-resistant helper phage TR-3 of the present invention can be widely used in phage display technology, and specifically can be used in the preparation of ssDNA, the preparation of antibody libraries, and the like. The phage display system containing TR-3 and phagemid can adapt to a wide range of cell culture temperatures for efficient production.
下面通过实施例对本发明作进一步说明。如无特别说明,实施例中的材料为根据现有方法制备而得,或直接从市场上购得。Below by embodiment the present invention will be further described. Unless otherwise specified, the materials in the examples were prepared according to existing methods, or were directly purchased from the market.
实施例1:耐高温M13KO7辅助噬菌体筛选Example 1: High temperature resistant M13KO7 assisted phage screening
1.生物淘筛:取2×1010个母本M13KO7辅助噬菌体(购买于美国NEB Biolab公司,货号:N0315S)于98℃孵育30min。12000g,离心10min后,取100μL上清,感染1mL NEB5alphaF’菌液(OD值为0.8),置于3D摇床中培养1hr;取部分感染后的菌液于2YT/Kan25涂板,置于37℃生化培养箱过夜。剩余菌液转入35mL 2YT/Kan25中,置于摇床中培养过夜,次日收集噬菌体,形成每轮的耐热辅助噬菌体库。重复上述步骤,直到R3轮耐高温的辅助噬菌体得到富集。1. Biological panning: Take 2×10 10 female parental M13KO7 helper phages (purchased from NEB Biolab, USA, item number: N0315S) and incubate at 98°C for 30 minutes. After centrifugation at 12000g for 10min, take 100μL supernatant, infect 1mL NEB5alphaF' bacterial solution (OD value 0.8), and culture it in a 3D shaker for 1hr; °C biochemical incubator overnight. The remaining bacterial liquid was transferred to 35mL 2YT/Kan25, placed in a shaker and cultured overnight, and the phages were collected the next day to form a heat-resistant auxiliary phage library for each round. Repeat the above steps until the R3 round of high temperature resistant helper phages are enriched.
2.通过辅助噬菌体产量对富集克隆进行优选:从R3轮筛选的2YT/Kan25平板中随机挑选5个克隆,命名为TR-1到TR-5,在35mL的2YT/Kan25培养基中过夜培养,次日收集辅助噬菌体。每个克隆分别取2×1010个辅助噬菌体,在98℃中孵育30min,12000g,离心10min后,取100μL上清,感染1mL NEB5alpaF’菌液(OD600值为0.8);培养1hr后,随后取20μL菌液进行适宜倍数的稀释,于LB/Tet10和LB/Kan25培养板上滴板,过夜培养,第二天将LB/Kan25培养板上的克隆数除以LB/Tet10培养板上的克隆数,获得克隆的感染效率(表1)。剩余菌液转入35mL2YT/Kan25培养基中培养过夜,次日收集辅助噬菌体;通过测定OD260比值(辅助噬菌体的OD260=2时,认定辅助噬菌体的浓度为1×1013pfu/mL),计算产量(表1)。挑选产量排名前三的TR-1、TR-3、和TR-4克隆继续实验。2. Optimizing the enriched clones based on the production of auxiliary phage: randomly select 5 clones from the 2YT/Kan25 plate screened in the R3 round, named TR-1 to TR-5, and culture them overnight in 35 mL of 2YT/Kan25 medium , and helper phages were collected the next day. Take 2×10 10 helper phages from each clone, incubate at 98°C for 30 minutes, centrifuge at 12000g for 10 minutes, take 100 μL of supernatant, and infect 1 mL of NEB5alpaF’ bacterial solution (OD 600 value is 0.8); after culturing for 1 hour, then Take 20 μL of the bacterial solution to dilute the appropriate multiple, drop the plate on the LB/Tet10 and LB/Kan25 culture plates, cultivate overnight, and divide the number of clones on the LB/Kan25 culture plate by the clones on the LB/Tet10 culture plate on the next day The infection efficiency of clones was obtained (Table 1). The remaining bacterial liquid was transferred to 35mL 2YT/Kan25 medium for overnight culture, and the helper phage was collected the next day; by measuring the OD260 ratio (when the OD260 of the helper phage=2, the concentration of the helper phage was determined to be 1×10 13 pfu/mL), and the yield was calculated (Table 1). Select the top three TR-1, TR-3, and TR-4 clones with the highest yield to continue the experiment.
表1.R3轮克隆的感染效率和辅助噬菌体产量Table 1. Infection efficiency and helper phage production of R3 round clones
3.通过超感染效率和抗体库噬菌体产量进行优选:从制备的天然羊驼抗体库(LibVHH)中取108个噬菌体,感染1mL NEB5alphaF’(OD值为0.8),置于37℃摇床培养1hr;再使用1010个TR-1、TR-3、和TR-4辅助噬菌体分别进行超感染,然后置于37℃摇床培养1hr。随后取20L菌液进行适宜倍数的稀释,于LB/Carb50和LB/Carb50/Kan25培养板上滴板,过夜培养,第二天将LB/Carb50/Kan25培养板上的克隆数除以LB/Carb50培养板上的克隆数,获得克隆的超感染效率(表2)。剩余菌液转入35mL的2YT/Carb50/Kan25过夜培养,第二天收集抗体库噬菌体,检测产量(表2)。结果表明:TR-3的超感染效率和抗体库产量更高,因此选择克隆TR-3作为我们的耐高温M13KO7辅助噬菌体。3. Optimizing by superinfection efficiency and antibody library phage yield: Take 108 phages from the prepared natural alpaca antibody library (LibVHH), infect 1mL NEB5alphaF' (OD value 0.8), and culture in a shaker at 37°C 1 hr; then use 10 10 TR-1, TR-3, and TR-4 helper phages to perform superinfection respectively, and then culture on a shaker at 37° C. for 1 hr. Then take 20L of the bacterial solution to dilute the appropriate multiple, drop the plate on the LB/Carb50 and LB/Carb50/Kan25 culture plates, cultivate overnight, and divide the number of clones on the LB/Carb50/Kan25 culture plate by LB/Carb50 the next day The number of clones on the culture plate was used to obtain the superinfection efficiency of the clones (Table 2). The remaining bacterial liquid was transferred to 35 mL of 2YT/Carb50/Kan25 for overnight culture, and the antibody library phages were collected the next day to detect the yield (Table 2). The results showed that the superinfection efficiency and antibody library yield of TR-3 were higher, so the clone TR-3 was selected as our thermostable M13KO7 helper phage.
表2.优选克隆的超感染效率和抗体库噬菌体产量Table 2. Superinfection efficiency and antibody library phage yield of preferred clones
实施例2:TR-3辅助噬菌体在抗体库制备中的应用Example 2: Application of TR-3 helper phage in antibody library preparation
1.全人抗体库的制备:从人外周血淋巴细胞提取RNA,并反转录成cDNA,经巢式PCR扩增获得抗体的Fab片段;通过Gibson Assembly反应,将PCR扩增所得的Fab基因片段与噬菌粒p3short连接;将连接产物纯化回收后,取1μg电转到100μL含有TR-3辅助噬菌体或者母本M13KO7辅助噬菌体的超级感受态细胞SS320中,之后在5mL SOC培养基中活化1hr。取20μL菌液进行适宜倍数的稀释,于LB/Carb50培养板上滴板,过夜培养,第二天统计克隆数,获得抗体库库容(表3)。将剩余菌液转入500mL的2YT/Carb50/Kan25,置于37℃摇床培养过夜,第二天收集抗体库噬菌体,检测产量(表3)。结果表明:使用含有TR-3辅助噬菌体的超级感受态细胞制备的抗体库(TR-3库),和使用含有母本M13KO7辅助噬菌体的超级感受态细胞制备的抗体库(M13KO7库),抗体库库容相当,但是TR-3库的噬菌体产量显著高于M13KO7库。1. Preparation of human antibody library: RNA was extracted from human peripheral blood lymphocytes, reverse-transcribed into cDNA, and the Fab fragment of the antibody was obtained by nested PCR amplification; the Fab gene obtained by PCR amplification was obtained by Gibson Assembly reaction The fragment was ligated with the phagemid p3short; after the ligation product was purified and recovered, 1 μg was electrotransferred into 100 μL supercompetent cells SS320 containing TR-3 helper phage or parental M13KO7 helper phage, and then activated in 5 mL SOC medium for 1 hr. Take 20 μL of the bacterial solution to dilute to an appropriate multiple, drop the plate on the LB/Carb50 culture plate, culture overnight, count the number of clones the next day, and obtain the capacity of the antibody library (Table 3). The remaining bacterial liquid was transferred to 500 mL of 2YT/Carb50/Kan25, placed in a shaker at 37°C for overnight culture, and the antibody library phages were collected the next day to detect the yield (Table 3). The results showed that: using the antibody library prepared by super competent cells containing TR-3 helper phage (TR-3 library), and using the antibody library prepared by super competent cells containing parental M13KO7 helper phage (M13KO7 library), the antibody library The library capacity is comparable, but the phage yield of the TR-3 library is significantly higher than that of the M13KO7 library.
2.抗体库滴度检测:从TR-3库和M13KO7库中,分别取108个噬菌体,感染1mLNEB5alphaF’(OD值为0.8),置于37℃摇床培养1hr;随后取20μL菌液进行适宜倍数的稀释,于LB/Carb50培养板上滴板,过夜培养,第二天统计克隆数,获得抗体库滴度(表3),结果表明:TR-3库的噬菌体滴度显著高于M13KO7库。2. Antibody library titer detection: Take 10 8 phages from TR-3 library and M13KO7 library respectively, infect 1mL NEB5alphaF' (OD value 0.8), place in a shaking table at 37°C for 1hr; Dilute the appropriate multiple, drop the plate on the LB/Carb50 culture plate, culture overnight, count the number of clones the next day, and obtain the titer of the antibody library (Table 3). The results show that the phage titer of the TR-3 library is significantly higher than that of M13KO7 library.
表3.抗体库的库容、产量和滴度Table 3. Storage capacity, yield and titer of the antibody library
实施例3:TR-3辅助噬菌体在ssDNA制备的应用Example 3: Application of TR-3 helper phage in ssDNA preparation
将含有Herceptin Fab的噬菌粒(4D5 Fab-short P3)转入CJ236细胞,活化1hr后,感染TR-3辅助噬菌体1hr(1×1012pfu/mL),转入2YT/carb50/kan25培养基,37℃摇菌过夜扩大培养,6000g离心10min,取出细胞。上清液中的噬菌体颗粒用PEG8000/NaCl沉淀,用1mL磷酸盐缓冲盐水(PBS)重悬。采用M-13DNA Isolation kit试剂盒(Omega Bio-tek,Norcross,GA,USA)提取噬菌体ssDNA,Nanodrop1000分光光度计定量,琼脂糖凝胶电泳分析。实验结果表明,耐高温TR-3辅助噬菌体感染的大肠杆菌,在37℃条件下培养后,可获得ssDNA。1%琼脂糖电泳鉴定结果表明(图1),获得的ssDNA具有与预期大小相同的单一条带,约2000bp,无肉眼可见的非特异性条带。The phagemid (4D5 Fab-short P3) containing Herceptin Fab was transferred into CJ236 cells, activated for 1 hr, infected with TR-3 helper phage for 1 hr (1×10 12 pfu/mL), and transferred into 2YT/carb50/kan25 medium , Shake the bacteria at 37°C overnight to expand the culture, centrifuge at 6000g for 10min, and take out the cells. Phage particles in the supernatant were precipitated with PEG8000/NaCl and resuspended with 1 mL of phosphate-buffered saline (PBS). Phage ssDNA was extracted using M-13DNA Isolation kit (Omega Bio-tek, Norcross, GA, USA), quantified by Nanodrop1000 spectrophotometer, and analyzed by agarose gel electrophoresis. The experimental results showed that Escherichia coli infected with thermostable TR-3 helper phage could obtain ssDNA after culturing at 37°C. The identification results of 1% agarose electrophoresis showed ( FIG. 1 ) that the obtained ssDNA had a single band with the same size as expected, about 2000 bp, and no non-specific bands visible to the naked eye.
实施例4:TR-3辅助噬菌体的基因测序Example 4: Gene sequencing of TR-3 helper phage
PCR扩增提取TR-3辅助噬菌体的基因,送往第三方进行基因测序,获得的序列与母本进行比较,在pVIII、pIII、和pIV基因区域发现多个氨基酸差异(表4),加粗和下划线标记的为突变的氨基酸。The gene of TR-3 helper phage was amplified and extracted by PCR, and sent to a third party for gene sequencing. The obtained sequence was compared with the mother parent, and multiple amino acid differences were found in the pVIII, pIII, and pIV gene regions (Table 4), bold and underlined are mutated amino acids.
表4.TR-3与母本M13KO7辅助噬菌体的氨基酸差异Table 4. Amino acid differences between TR-3 and the parent M13KO7 helper phage
最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。Finally, it should be noted that: the above embodiments are only used to illustrate the technical solutions of the present invention, rather than limiting them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: It is still possible to modify the technical solutions described in the foregoing embodiments, or perform equivalent replacements for some or all of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the technical solutions of the various embodiments of the present invention. scope.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210887757.1A CN115820567B (en) | 2022-07-26 | 2022-07-26 | Thermoresistant helper phage TR-3 and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210887757.1A CN115820567B (en) | 2022-07-26 | 2022-07-26 | Thermoresistant helper phage TR-3 and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115820567A true CN115820567A (en) | 2023-03-21 |
CN115820567B CN115820567B (en) | 2025-06-06 |
Family
ID=85522907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210887757.1A Active CN115820567B (en) | 2022-07-26 | 2022-07-26 | Thermoresistant helper phage TR-3 and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115820567B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110052565A1 (en) * | 2007-12-21 | 2011-03-03 | National Research Council Of Canada | Non-aggregating human vh domains |
CN104870008A (en) * | 2012-10-02 | 2015-08-26 | 神经噬菌体制药股份有限公司 | Use of P3 of bacteriophage fusion proteins as amyloid binding agents |
CN108250295A (en) * | 2018-01-16 | 2018-07-06 | 福州大学 | A kind of method using phage antibody library screening estrogen receptor alpha single chain antibody |
CN111801345A (en) * | 2017-07-28 | 2020-10-20 | 哈佛大学的校长及成员们 | Methods and compositions using an evolved base editor for Phage Assisted Continuous Evolution (PACE) |
WO2024006774A2 (en) * | 2022-06-27 | 2024-01-04 | Beam Therapeutics Inc. | Compositions and methods for non-genotoxic cell conditioning |
-
2022
- 2022-07-26 CN CN202210887757.1A patent/CN115820567B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110052565A1 (en) * | 2007-12-21 | 2011-03-03 | National Research Council Of Canada | Non-aggregating human vh domains |
CN104870008A (en) * | 2012-10-02 | 2015-08-26 | 神经噬菌体制药股份有限公司 | Use of P3 of bacteriophage fusion proteins as amyloid binding agents |
CN111801345A (en) * | 2017-07-28 | 2020-10-20 | 哈佛大学的校长及成员们 | Methods and compositions using an evolved base editor for Phage Assisted Continuous Evolution (PACE) |
CN108250295A (en) * | 2018-01-16 | 2018-07-06 | 福州大学 | A kind of method using phage antibody library screening estrogen receptor alpha single chain antibody |
WO2024006774A2 (en) * | 2022-06-27 | 2024-01-04 | Beam Therapeutics Inc. | Compositions and methods for non-genotoxic cell conditioning |
Non-Patent Citations (1)
Title |
---|
HONG LIU等: "Potential Applications of Thermophilic Bacteriophages in One Health", 《INT J MOL SCI.》, vol. 24, no. 9, 4 May 2023 (2023-05-04), pages 8222 * |
Also Published As
Publication number | Publication date |
---|---|
CN115820567B (en) | 2025-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Noren et al. | Construction of high-complexity combinatorial phage display peptide libraries | |
Bratkovič | Progress in phage display: evolution of the technique and its applications | |
Hoess | Protein design and phage display | |
US7901919B2 (en) | Chimaeric phages | |
US5338665A (en) | Peptide library and screening method | |
Hendrix et al. | Bacteriophage l and its genetic neighborhood | |
Hendrix et al. | Bacteriophage HK97 capsid assembly and maturation | |
EP1892296A1 (en) | Generation and selection of recombinant varied binding proteins | |
Feiss et al. | Bacteriophage lambda terminase and the mechanism of viral DNA packaging | |
CN101213299A (en) | Phage display using co-translational transport of fusion polypeptides | |
KR20010052894A (en) | Method for producing polynucleotides with desired properties | |
JPH09506000A (en) | How to select specific bacteriophage | |
Scholle et al. | Efficient construction of a large collection of phage-displayed combinatorial peptide libraries | |
EP0742821B1 (en) | Method for preparing a multicombinatorial library of antibody gene expression vectors | |
US8969253B2 (en) | Method for screening phage display libraries against each other | |
Garufi et al. | Display libraries on bacteriophage lambda capsid | |
Crameri | pJuFo: a phage surface display system for cloning genes based on protein-ligand interaction | |
CN115820567A (en) | High-temperature-resistant helper phage TR-3 and application thereof | |
EP1390489B1 (en) | Phagemid vectors | |
Fagerlund et al. | Construction and characterization of a 9-mer phage display pVIII-library with regulated peptide density | |
CN101772574A (en) | Improved methods for the formation of disulphide bonds | |
WO2007109823A2 (en) | Peptide library | |
CN117467693A (en) | Genome editing vector and application | |
US20050130124A1 (en) | Phagemid display system | |
KR20110003547A (en) | Artificial protein scaffold |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |